Residential exposome and the risk of coronary obstruction and myocardial ischaemia detected by coronary computed tomography - Top-Institutions - MDSpire

Residential exposome and the risk of coronary obstruction and myocardial ischaemia detected by coronary computed tomography

  • By

  • Tom De Potter

  • Andreea Motoc

  • Els Verachtert

  • Hans Hooyberghs

  • Kaoru Tanaka

  • Dries Belsack

  • Diederik De Cock

  • Frans Fierens

  • Toshimitsu Tsugu

  • Tim Nawrot

  • Marc Claeys

  • Bernard Cosyns

  • Jean-François Argacha

  • February 19, 2025

  • 0 min

Share

Top Institutions in Cardiology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Cardiology
    • Cardiovascular Imaging
    • Environmental Health

  • #2

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Cardiology
    • Radiology
    • Environmental Medicine

  • #3

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Cardiology
    • Environmental Health Sciences
    • Radiology

  • #4

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Cardiology
    • Cardiovascular Imaging

  • #5

    Harvard T.H. Chan School of Public Health
    Harvard T.H. Chan School of Public Health

    Boston, MA

    Key Differentiators

    • Environmental Health
    • Epidemiology
    • Cardiovascular Disease Prevention

Original Source(s)

Residential exposome and the risk of coronary obstruction and myocardial ischaemia detected by coronary computed tomography

  • by Tom De Potter, Andreea Motoc, Els Verachtert, Hans Hooyberghs, Kaoru Tanaka, Dries Belsack, Diederik De Cock, Frans Fierens, Toshimitsu Tsugu, Tim Nawrot, Marc Claeys, Bernard Cosyns, Jean-François Argacha

  • February 19, 2025

Related Content

Limonin Reduces Pyroptosis and Inflammation in Myocardial Ischemia-Reperfusion Mice by Targeting the Caspase-3/GSDME Pathway

GLP-1 Drugs Tied to Lower Addiction Risk

In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.

Retatrutide Shows 28% Weight Loss in Phase 3 Trial

Nearly half of participants receiving the highest dose achieved at least 30% body weight reduction.